Medical Breakthroughs Reliant on Better Clinical Trials
Source: PRWeb The cost of patients dropping out of clinical trials continues to be a major problem for the development of new drugs and treatments
Source: PRWeb The cost of patients dropping out of clinical trials continues to be a major problem for the development of new drugs and treatments
Partnering for Success: the Pioneers of Affordable CAR-T Cell/Gene Therapy for Leukemias and Lymphomas. ImmunoAct ImmunoACT is pioneering the first affordable cell and gene therapies
Connect rare disease patients of Indian diaspora everywhere with information, resources, experts, diagnostics, treatment options, and clinical trials. Customer: Indo US RARE Indo US Organization
Health outcomes and biomarkers data collection for persons with neurodevelopmental disorders to accelerate treatment options Customer: COMBINEDBrain The Consortium for Outcome Measures and Biomarkers for
Remote Video eConsent for a Biospecimen Collection Study with Pediatric and Maternal Patients Customer: Childrens National Hospital #5 childrens hospital in the United States serving
Patient registry for muscular dystrophies to accelerate #Genetherapy development Customer: Cure Rare Disease curerd.org is on a mission to research and develop cost-effective, lifesaving long-term therapies
Source: PRWeb Dr. Harsha Rajasimha, Founder and CEO of Jeeva Trials, highlights the importance and value of Investigator-Initiated Trials (IITs) in gathering real-world data on
Source: Onco’Zine The Inflation Reduction Act of 2022 (IRA) covers new and reinstated tax laws that will affect individuals and businesses. Through IRA, President Joe
Source: PRWeb Drug pricing controls imposed by the Inflation Reduction Act of 2022 may appear positive for patients in the short term. However, these controls
Source: EIN News CCF grants support startups, critical early technology testing and market validation efforts. RICHMOND, VIRGINIA, UNITED STATES, June 27, 2023/EINPresswire.com/ — The Virginia
Jeeva Clinical Trials Inc.